# A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers

> **NCT02972255** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 46 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** RO7079901
- **DRUG:** Meropenem
- **OTHER:** RO7049389 Placebo
- **OTHER:** Meropenem Placebo

## Key facts

- **NCT ID:** NCT02972255
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-31
- **Primary completion:** 2017-03-24
- **Final completion:** 2017-03-24
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972255, "A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02972255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*